Literature DB >> 10420726

[Hereditary angioedema. Diagnostic and treatment errors as systemic lupus erythematosus].

P Harten1, D Körbächer, C Renk, H H Euler, H Löffler.   

Abstract

BACKGROUND: Symptoms of hereditary angioedema are intermittent edema of subcutaneous tissues, abdominal organs, upper airways, and brain. Because of spontaneous mutation, in 20% of patients a familial history is lacking. Serological hallmarks are diminished complement factor 4 and C1-esterase inhibitor. The heterogenicity of the clinical symptoms frequently leads to false or delayed diagnosis. CASE REPORT: We report on a 50-year-old male patient with intermittent joint swellings, abdominal complaints, pleural effusions, ascites and headaches with disturbances of consciousness since early adulthood. Diagnosis was systemic lupus erythematosus. Immunosuppressive therapy was ineffective over months. Careful re-evaluation of the patient's clinical history and further laboratory examinations led to the diagnosis of an hereditary angioedema. Anamnestic and laboratory exploration of family members disclosed four other cases. Two of them also were symptomatic for decades without adequate diagnosis.
CONCLUSION: In case of intermittent swellings, abdominal complaints, laryngeal edema, pleural effusions or ascites, differential diagnosis should involve hereditary angioedema. With early diagnosis and adequate treatment, prognosis is good. Since ACE inhibitors can aggravate the disease they are contraindicated. Diagnosis, pathogenesis, and treatment are discussed by reviewing the literature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10420726     DOI: 10.1007/bf03044893

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  28 in total

Review 1.  Angioedema and C1 inhibitor deficiency.

Authors:  N A Orfan; G B Kolski
Journal:  Ann Allergy       Date:  1992-09

2.  Hereditary angioedema: the clinical syndrome and its management.

Authors:  M M Frank; J A Gelfand; J P Atkinson
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

3.  Hereditary angioedema.

Authors:  M Cicardi; A Agostoni
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

4.  C3 is activated in hereditary angioedema, and C1/C1-inhibitor complexes rise during physical stress in untreated patients.

Authors:  E W Nielsen; H T Johansen; O Gaudesen; B Osterud; J O Olsen; K Høgåsen; C E Hack; T E Mollnes
Journal:  Scand J Immunol       Date:  1995-12       Impact factor: 3.487

5.  Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.

Authors:  M Cicardi; L Bergamaschini; M Cugno; E Hack; G Agostoni; A Agostoni
Journal:  J Allergy Clin Immunol       Date:  1991-04       Impact factor: 10.793

6.  The long-term safety of danazol in women with hereditary angioedema.

Authors:  J J Zurlo; M M Frank
Journal:  Fertil Steril       Date:  1990-07       Impact factor: 7.329

7.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

Authors:  J A Gelfand; R J Sherins; D W Alling; M M Frank
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  [Long-term danazol therapy for hereditary angioedema].

Authors:  R Höpfl; S Schwarz; P Fritsch; H Hintner
Journal:  Dtsch Med Wochenschr       Date:  1990-01-26       Impact factor: 0.628

9.  Oral manifestations and dental management of patients with hereditary angioedema.

Authors:  J C Atkinson; M M Frank
Journal:  J Oral Pathol Med       Date:  1991-03       Impact factor: 4.253

10.  Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.

Authors:  A E Davis; A S Whitehead; R A Harrison; A Dauphinais; G A Bruns; M Cicardi; F S Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.